Applied Imaging Corp designs, develops, manufactures and markets automated image analysis systems used by cytogenetic laboratories. The Company's cytogenetic instrumentation and reagent business, which has sold systems to over 650 sites in more than 35 countries since its inception, markets computer-based microscopic image analysis systems that enable laboratories to automate the analysis of chromosomal abnormalities associated with conditions such as Down Syndrome. The Company is also developing a proprietary genetic screening technology designed to facilitate prenatal screening for genetic abnormalities by isolating fetal blood cells from a routine maternal blood sample. In addition, the Company has under development a system to detect micrometastatic cells from bone marrow, lymph node and blood samples from cancer patients as a means to better determine the initial staging of the cancer and then detect relapses after treatment earlier than is currently possible.
This company provides the tools for genomics research and application, and seems to have a glowing future. |
